4.5 Article

Prognostic performance of low-dose coronary CT angiography with prospective ECG triggering

Journal

HEART
Volume 97, Issue 17, Pages 1385-1390

Publisher

B M J PUBLISHING GROUP
DOI: 10.1136/hrt.2010.217638

Keywords

-

Funding

  1. Swiss National Science Foundation
  2. Zurich Center for Integrative Human Physiology, University of Zurich, Switzerland

Ask authors/readers for more resources

Objective To assess the prognostic value of low-dose 64-slice coronary CT angiography (CCTA) using prospective ECG triggering in a patient population with known or suspected coronary artery disease (CAD). Design Longitudinal follow-up study. Setting Tertiary referral cardiac imaging centre. Patients 434 consecutive patients who were referred for evaluation of CAD by CCTA. Methods The presence, distribution and severity of coronary lesions (non-obstructive < 50% vs obstructive >= 50% luminal narrowing) were recorded by low-dose prospective ECG-triggered CCTA for each patient. The prognostic value of low-dose CCTA to predict major adverse cardiac events, defined as cardiac death, non-fatal myocardial infarction, or the need for revascularisation, was assessed using multivariate Cox regression analysis. Each person was followed up by telephone interviews and/or on the basis of clinical records. Thirty-eight early revascularised patients were excluded from outcome analysis. Results Completely normal coronary arteries were documented in 171 patients (47%), while exclusively non-obstructive lesions were found in 66 (18%), and obstructive coronary lesions were diagnosed in 130 patients (35%). A mean follow-up of 47 +/- 16 weeks was obtained. The first-year event rate was 0% in patients with normal coronary arteries on CCTA but increased to 3% and 26% in patients with non-obstructive and obstructive coronary artery lesions, respectively. In multivariate Cox regression analysis, a significant predictor of events was the presence of obstructive or any coronary lesions. Mean effective radiation dose was 1.8 +/- 0.6 mSv. Conclusions These data document an excellent prognostic performance of low-dose CCTA.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available